Aprosencephaly is a rare genetic/congenital condition where the front part of the brain does not form. It is usually recognized before birth or at delivery and has severe features affecting head size, facial structure, and brain development. Babies with aprosencephaly typically have trouble breathing, feeding, and moving, and seizures can occur. The condition is usually not compatible with long-term survival, and many infants die shortly after birth. Care focuses on comfort, assisted breathing and feeding when possible, and support for families.
Overview
AprosencephalySymptoms
Aprosencephaly is recognized before birth or at delivery. Early signs of aprosencephaly include a very small head, facial differences, poor responsiveness, and trouble breathing or feeding. Doctors may also note seizures and severe problems with movement and body temperature control.
Outlook and prognosis
Many living with Aprosencephaly have very serious brain underdevelopment that begins before birth. Most pregnancies end in miscarriage or stillbirth, and infants who are born typically survive only hours to days. Supportive care focuses on comfort for the baby and family.
Causes and risk factors
Aprosencephaly usually stems from early developmental genetic changes—sometimes inherited, often new. Chromosomal abnormalities and consanguinity can raise risk. Maternal factors during early pregnancy—uncontrolled diabetes, alcohol, retinoic acid–containing medicines, and certain infections—may increase risk factors for Aprosencephaly.
Genetic influences
Genetics play a central role in Aprosencephaly; many cases result from rare variants affecting early brain formation pathways. Inheritance can be autosomal recessive or sporadic. Genetic testing and counseling help clarify recurrence risk and guide family planning.
Diagnosis
Clinicians suspect aprosencephaly on prenatal ultrasound or fetal MRI, or after birth with neurologic exam and brain imaging. Imaging findings confirm the diagnosis of aprosencephaly. Genetic diagnosis of aprosencephaly, through chromosomal or gene testing, can guide counseling.
Treatment and drugs
Care focuses on comfort, nutrition, and preventing complications. Treatment for Aprosencephaly may include feeding support, seizure control, breathing assistance, and careful skin and infection care, tailored by neonatology, neurology, palliative care, and social work teams.
Symptoms
Aprosencephaly affects the brain very early in development, so differences are usually noticed before or at birth. Clinicians call this aprosencephaly, which means the forebrain did not form. For newborns, this often leads to breathing and feeding difficulties, seizures, and very limited responsiveness. In many pregnancies, early features of Aprosencephaly are seen on routine ultrasound or fetal MRI, and survival after birth is usually short.
A routine ultrasound may show a severe lack of forebrain structures and a very thin or absent top part of the brain. Fetal MRI can help confirm the pattern in Aprosencephaly.
Babies are often born with a very small head (microcephaly) or an unusual skull shape because large parts of the brain did not form. In Aprosencephaly, the soft spots may feel wider or shaped differently.
Midline facial changes can include a cleft lip or palate, a very small or absent nose, or closely spaced eyes. These features reflect how the developing forebrain guides face formation.
Newborns may have pauses in breathing or shallow breaths right after delivery. Many with Aprosencephaly need oxygen or a breathing machine for support.
How people usually first notice Aprosencephaly?
Many families first learn something is different during a routine pregnancy ultrasound, when the baby’s forebrain structures aren’t visible and the head may appear unusually shaped. If not found prenatally, doctors typically recognize it at birth because the upper parts of the brain and skull are missing, with severe abnormalities of the face and head. In practice, the first signs of aprosencephaly are almost always detected before or at delivery through imaging and the newborn’s physical features.
Types of Aprosencephaly
Aprosencephaly is a rare congenital brain malformation, present from early pregnancy, and is considered part of the holoprosencephaly spectrum. Variants of Aprosencephaly are defined by how early brain development arrests and how the forebrain and facial structures are affected. Not everyone will experience every type. Clinicians often describe them in these categories:
Type 1 (complete)
The forebrain fails to form and the cerebral hemispheres are absent. The thalami and basal ganglia may be partially present but are abnormal. This form is typically incompatible with survival beyond the newborn period.
Type 2 (partial)
There is severe underdevelopment of the forebrain with rudimentary cerebral tissue. Brain structures that usually separate the left and right sides are missing or fused. Outcomes are very poor, but limited brain tissue may change specific features seen on imaging.
With cyclopia
Aprosencephaly occurs with a single midline eye or partially fused eyes and severe facial anomalies. Breathing and feeding are usually not sustainable without intensive support. These variants of Aprosencephaly reflect very early disruptions in midline development.
With proboscis
A tubular nasal structure (proboscis) sits above the eye area alongside severe forebrain maldevelopment. The normal nose is typically absent and facial midline structures are profoundly affected. Types of Aprosencephaly that include facial anomalies often indicate extremely early developmental arrest.
With microphthalmia
Very small eyes (microphthalmia) accompany the absent or rudimentary forebrain. Vision is not expected, and other organ anomalies may also occur. This variant’s features depend on how widespread early head and facial development was affected.
What genetics can tell you about symptoms
Certain ALX gene variants can disrupt early brain and face formation, leading to absent forebrain structures, severe facial differences, profound developmental delay, and seizures. When these genes act like stuck “off” switches, pregnancy loss or life-limiting outcomes are common.
Causes and risk factors
Aprosencephaly begins very early in pregnancy when the forebrain does not form, often without a clear trigger. The genetic causes of aprosencephaly often involve new (de novo) changes, and less often inherited ones. Doctors distinguish between risk factors you can change and those you can’t. Non-modifiable risks include chromosome differences in the fetus and a history of similar brain malformations in a prior pregnancy. Modifiable risks include poorly controlled diabetes before or early in pregnancy and exposure to certain harmful medicines or toxins.
Environmental and biological risk factors
Aprosencephaly is a very rare condition present at birth in which the forebrain does not form. This overview highlights environmental and biological risk factors for Aprosencephaly that act in the earliest weeks of pregnancy. Doctors often group risks into internal (biological) and external (environmental). Most influences that raise risk happen very early, sometimes before pregnancy is recognized.
High blood sugar around the time of conception can interfere with early brain development. This has been linked with severe forebrain malformations, including rare conditions such as aprosencephaly.
Infections such as rubella, cytomegalovirus, or Zika in the first trimester can disrupt brain formation. Severe early infection may increase the likelihood of aprosencephaly.
Drugs related to vitamin A, such as isotretinoin for severe acne, can cause major brain and facial malformations when taken in early pregnancy. Early exposure increases the chance of severe forebrain defects like aprosencephaly.
Some antiseizure medications have been associated with higher rates of serious birth defects when used early in pregnancy. Risk varies by medication and dose, with the first weeks being most sensitive.
Genetic risk factors
Most cases trace back to major genetic changes that disrupt very early forebrain development. Risk is not destiny—it varies widely between individuals. Genetic risk factors for aprosencephaly include single-gene variants in brain-patterning pathways and larger chromosome changes. Many arise for the first time, while others can be inherited, sometimes with only subtle signs in a parent.
HPE pathway genes: Variants in genes like SHH, ZIC2, SIX3, or TGIF1 can severely disrupt forebrain formation. These are usually autosomal dominant with variable effects in a family. Rarely, the most severe end of this spectrum can present as aprosencephaly.
Chromosomal aneuploidy: Extra or missing whole chromosomes, such as trisomy 13 or triploidy, can interfere with early brain patterning. These changes often arise by chance and are not usually inherited. In these settings, aprosencephaly may occur alongside other major anomalies.
Chromosomal deletions: Loss of pieces of chromosomes, for example 13q or 18p deletions, can remove key brain-development genes. This can lead to severe midline malformations, sometimes including aprosencephaly. The change may be new in the child or come from a parent with a balanced rearrangement.
Copy-number variants: Small stretches of DNA can be missing (microdeletions) or extra (microduplications). When these include brain-patterning genes, the result can be profound forebrain underdevelopment. These imbalances may be de novo or inherited.
De novo variants: In many families, the causative change is new in the child and not present in either parent. This typically means a lower chance of recurrence in future pregnancies, though not zero.
Reduced penetrance: Some inherited variants do not cause obvious features in a parent but can lead to severe outcomes in a child. Mild midline facial differences, such as a single central incisor, may be the only signs in carriers. This hidden pattern can mask family risk.
Recessive causes: Rarely, aprosencephaly follows an autosomal recessive pattern in which both parents silently carry one nonworking copy of the same gene. With each pregnancy, the chance of an affected child is 25% (1 in 4). This pattern is more likely when parents are related by blood.
Parental mosaicism: Occasionally, a parent carries the variant in only a small fraction of egg or sperm cells. This can raise recurrence risk even when standard parental testing is negative. Specialized counseling can help estimate this risk.
Family history: A history of holoprosencephaly, a single central incisor, or other midline differences can signal higher genetic risk. Sharing this detail helps clinicians target the right genes and chromosome regions. It can also guide counseling for future pregnancies.
NODAL pathway genes: Variants affecting NODAL signaling, such as NODAL or FOXH1, have been linked to holoprosencephaly in recessive or complex patterns. In rare cases, severe outcomes can include aprosencephaly. Effects can vary widely between families.
Lifestyle risk factors
Aprosencephaly is a congenital brain malformation; lifestyle habits do not cause it, but day-to-day care can influence comfort, complications, and hospitalizations. Focusing on how lifestyle affects Aprosencephaly highlights practical steps families can take alongside medical care. The following elements emphasize routines and care practices that may reduce respiratory, nutritional, skin, and seizure-related complications. These reflect lifestyle risk factors for Aprosencephaly in the context of supportive and palliative care.
Using clinician-guided feeding methods and pacing can reduce aspiration and discomfort. Adequate calories and hydration support growth and energy for breathing and healing. Skipping safe-feeding strategies raises the risk of pneumonia and hospital visits.
Upright positioning during and after feeds and, when advised, thickened feeds lower aspiration risk. Inconsistent use of these precautions can lead to coughing, choking, and recurrent respiratory infections.
Giving anti-seizure medicines on schedule and tracking triggers can reduce seizure frequency. Missed doses and irregular routines often increase breakthrough seizures and emergency care.
A consistent sleep-wake routine may lessen irritability and lower seizure thresholds. Fragmented or very short sleep can worsen seizures and feeding tolerance.
Risk prevention
Aprosencephaly develops very early in pregnancy and, in most cases, can’t be truly prevented. Prevention focuses on reducing overall risks for severe brain malformations and finding problems early in pregnancy. Even if you can’t remove all risks, prevention can reduce their impact. Care before and during pregnancy, plus timely prenatal screening, offers the best chance to lower risk and prepare.
Taking 400–800 micrograms (0.4–0.8 mg) of folic acid daily before conception and in early pregnancy supports early brain and spine development. While it can’t prevent Aprosencephaly outright, it lowers the risk of related major birth defects.
If you live with diabetes, aim for well-controlled blood sugar before pregnancy and throughout the first trimester. Good control can reduce the chance of serious congenital brain malformations, including conditions like Aprosencephaly.
Do not drink alcohol and avoid recreational drugs before and during pregnancy. Limiting exposure to harmful chemicals and high-dose vitamin A medicines reduces the risk of major birth defects that can involve the brain.
Review all prescriptions, over-the-counter medicines, and supplements with your clinician when planning pregnancy. Switching from higher-risk medicines to safer alternatives may lower the chance of severe brain malformations like Aprosencephaly.
Transmission
Aprosencephaly is not infectious and cannot be passed from one person to another. It is a congenital condition that begins during very early fetal development.
In some families, Aprosencephaly can be inherited in an autosomal recessive way, while many cases happen as a new genetic change or a chromosome difference with no prior family history. Because the genetic transmission of Aprosencephaly varies by cause, the chance of it happening again can be low for new (de novo) cases or about 25% per pregnancy in recessive families; a genetics professional can explain how Aprosencephaly is inherited in your situation.
When to test your genes
Aprosencephaly is a severe congenital brain malformation detected prenatally by ultrasound or MRI, and genetic testing is typically pursued during pregnancy after such findings or prior losses. Test genes when a fetus shows forebrain/craniofacial anomalies, or after an affected pregnancy, to clarify cause and recurrence risk. Preconception carrier testing and targeted prenatal panels can guide future planning.
Diagnosis
Aprosencephaly is usually identified during pregnancy when routine scans show a major difference in brain development. Diagnosis centers on what doctors can see on imaging, then confirming details with targeted tests. Early and accurate diagnosis can help you plan ahead with confidence. In some cases, testing after birth or after pregnancy loss provides the clearest answers for the family.
Standard mid‑pregnancy scans can show absent or severely underdeveloped forebrain structures and related facial differences. Findings are often visible in the second trimester. Follow‑up imaging helps confirm the pattern.
MRI offers a closer look at brain structure and connections when ultrasound shows significant concerns. It can clarify the extent of forebrain absence and better define other features. This helps distinguish Aprosencephaly from related conditions.
If a baby is born, clinicians look for features that match severe forebrain underdevelopment. They also assess breathing, feeding, and reflexes to understand immediate needs. Physical findings guide which tests to do next.
Head ultrasound, MRI, or CT can document the brain differences in detail after birth. Imaging patterns confirm the extent of missing forebrain tissue. These studies also look for other brain or skull findings that affect care.
Stages of Aprosencephaly
Aprosencephaly does not have defined progression stages. It’s a severe structural brain difference that forms very early in pregnancy and does not unfold gradually; it is usually identified before birth or immediately after delivery. There are no early symptoms of Aprosencephaly that a pregnant person would notice, so doctors rely on prenatal ultrasound and sometimes fetal MRI to confirm the diagnosis. Different tests may be suggested to help clarify the picture, and genetic testing may be offered to understand possible causes.
Outlook and prognosis
Looking at the long-term picture can be helpful. Aprosencephaly is a severe brain development disorder present from early pregnancy, and most pregnancies affected end in miscarriage, stillbirth, or death shortly after birth. For the rare newborns who survive delivery, breathing, heart rhythm, and body temperature are often difficult to maintain without intensive support. Many people ask, “What does this mean for my future?”, but in aprosencephaly the prognosis is unfortunately very poor, with survival beyond the first days of life uncommon.
Doctors call this the prognosis—a medical word for likely outcomes. Because key brain structures do not form, feeding, movement, and responsiveness are profoundly limited, and seizures can occur. When families ask about early symptoms of aprosencephaly during pregnancy, clinicians usually point to findings on prenatal ultrasound or MRI rather than outward signs, since the condition is detected by imaging rather than by how the pregnant person feels.
Support from friends and family can help families navigate stressful decisions, including planning for delivery, comfort-focused care, and memory-making if a baby is not expected to live long. Palliative care teams often join early to align medical care with family values, whether that involves brief life-prolonging measures or a focus on comfort only. Talk with your doctor about what your personal outlook might look like, including options for prenatal testing in a future pregnancy and whether genetic counseling could clarify recurrence risks.
Long-term effects
Aprosencephaly is a rare, severe brain development condition with a very limited life expectancy. Long-term effects vary widely, but most pregnancies end in loss or babies pass away shortly after birth. In the rare instances of longer survival, profound developmental and medical needs are expected throughout life. Families often ask about the long-term prognosis of aprosencephaly; doctors base this on the extent of brain formation and any related organ differences.
Many pregnancies end in miscarriage or stillbirth. Newborns with aprosencephaly often survive only hours to days. Longer survival is uncommon and typically involves intensive medical support.
Profound developmental impairment is expected in survivors. People living with aprosencephaly typically do not achieve typical milestones such as sitting, speaking, or purposeful interaction.
Irregular breathing and poor coordination for sucking and swallowing are common features. This can lead to aspiration and require assisted feeding and respiratory support.
Seizure activity often occurs due to severe brain malformation. Episodes may be frequent and hard to control over time.
How is it to live with Aprosencephaly?
Living with aprosencephaly is not something most families experience over years; it is a severe brain malformation present from birth, and many newborns do not survive long after delivery. For parents and loved ones, daily life becomes focused on comfort care, gentle touch, and navigating complex emotions and decisions with the medical team. When babies do survive beyond the newborn period, care often involves managing feeding and breathing support, seizures, and profound developmental differences, with hospice or palliative care guiding comfort and quality of life. Families around the child may feel a mix of love, grief, and uncertainty, and many find strength through counseling, spiritual support, and communities who understand this rare journey.
Treatment and drugs
Treatment for aprosencephaly focuses on comfort and supportive care, because there is no cure and no surgery or medicine that can form missing parts of the brain. Babies with aprosencephaly often have severe breathing, feeding, and temperature‑regulation problems, so care teams work to ease distress with oxygen or assisted ventilation, careful feeding plans (including tube feeding), and measures to prevent infections and pressure sores. Seizures, if they occur, may be treated with anti‑seizure medicines, and clinicians may use medicines to reduce muscle stiffness or help with irritability and pain. Alongside medical treatment, lifestyle choices play a role, as families coordinate palliative care, home nursing, and equipment such as special positioning devices to keep the child comfortable. Supportive care can make a real difference in how you feel day to day, and palliative specialists can guide families through decision‑making, symptom relief, and emotional support.
Non-drug treatment
Families often focus on comfort, safe feeding, and breathing support in day-to-day care, with attention to preventing sores and easing stiffness. Beyond prescriptions, supportive therapies can guide positioning, communication methods, and home equipment choices. Care plans usually center on quality of life, symptom relief, and coordinating services across hospital and home. During pregnancy, early symptoms of aprosencephaly may be seen on scans, allowing time to discuss goals of care and supports.
A team helps focus on comfort, symptom relief, and family goals. They coordinate care across settings and adjust plans as needs change.
Gentle airway suctioning and careful positioning can reduce breathing effort. Some families use oxygen or humidification to ease comfort.
A speech or feeding therapist checks for safe swallowing and aspiration risk. If needed, tube feeding can provide nutrition with less stress.
Supportive cushions and frequent repositioning help prevent pressure sores and stiffness. Simple range-of-motion exercises can maintain comfort.
Your genes may have an impact on how drugs work for you
Medicines used around aprosencephaly—such as anti-seizure drugs, muscle tone agents, or sedatives—can work differently depending on genes that shape how the body breaks down or responds to them. Genetic differences may change dose needs or side‑effect risk, guiding personalized choices.
Pharmacological treatments
For Aprosencephaly, there isn’t a cure, so medicines focus on easing symptoms and keeping your child as comfortable as possible. Drugs that target symptoms directly are called symptomatic treatments. Care plans are highly individualized, guided by the specific features your child has and how they change over time. Decisions usually happen within a supportive, palliative approach alongside nutrition, therapy, and careful monitoring.
Levetiracetam or phenobarbital are commonly used to prevent seizures. Midazolam or lorazepam may be given for sudden seizure clusters. Seizures can be one of the early symptoms of Aprosencephaly.
Baclofen or diazepam can ease tight, stiff muscles and reduce painful spasms. This may help positioning, caregiving, and comfort for children with Aprosencephaly.
Acetaminophen (paracetamol) can help with mild pain or fever. Morphine or oxycodone may be considered for more severe pain or breathing discomfort in Aprosencephaly.
Glycopyrrolate or scopolamine can reduce drooling and thick airway secretions. This may lower choking risk and make breathing care easier.
Genetic influences
In aprosencephaly, genetic factors can influence how the forebrain forms very early in pregnancy. In some pregnancies, a change in a single gene or a difference in chromosome number or structure is identified; in others, it seems to occur for the first time in the child without a known family pattern. Rare families show an inherited pattern in which both parents carry the same gene change and more than one pregnancy is affected. A “carrier” means you hold the gene change but may not show symptoms. Because the genetic causes of aprosencephaly are varied, genetic testing for aprosencephaly may include chromosome analysis and broader gene-based tests, and sometimes no clear answer is found. A genetics team can review your family history, explain recurrence risk for future pregnancies, and discuss options such as prenatal testing when appropriate.
Is Aprosencephaly genetic?
Genetics play a central role in Aprosencephaly; many cases result from rare variants affecting early brain formation pathways. Inheritance can be autosomal recessive or sporadic. Genetic testing and counseling help clarify recurrence risk and guide family planning.
Pharmacogenetics—how genetics influence drug effects
There’s no targeted drug for aprosencephaly; care focuses on comfort and on treating symptoms such as seizures, feeding challenges, and breathing problems. Even so, inherited differences can affect how a child responds to common supportive medicines. Genes can influence how quickly you process certain seizure medicines, sedatives, and pain relievers, which can change both dose needs and the chance of side effects. In seizure care, some HLA types are linked to severe skin reactions with carbamazepine in people of certain Asian backgrounds, and differences in liver‑enzyme genes (such as CYP2C9) can raise phenytoin levels; doctors also avoid valproate when a POLG‑related mitochondrial disorder is suspected or confirmed. For pain control, codeine and tramadol are generally avoided in children because some people rapidly convert them into high morphine levels, which can slow or stop breathing; this risk relates to inherited CYP2D6 differences. For reflux or calming medicines, variants in drug‑handling enzymes (for example, CYP2C19 with omeprazole or diazepam) may call for dose adjustments or a different drug. The specific gene change causing aprosencephaly rarely changes medication choice today, but broader pharmacogenetic information can help tailor supportive treatments while the care team closely watches real‑world response.
Interactions with other conditions
Pregnancies affected by Aprosencephaly often show differences beyond the brain, with changes seen in the face, heart, kidneys, or limbs during prenatal scans. Doctors call it a “comorbidity” when two conditions occur together. In some cases, Aprosencephaly appears alongside chromosomal conditions such as trisomy 13 or triploidy, and with other midline features like a single eye socket or a very small or absent nose. Maternal health can also play a role—preexisting diabetes has been linked to higher risk, and certain early-pregnancy exposures may increase the chance of severe brain development problems. Because Aprosencephaly is usually very severe and not compatible with long-term survival, these interactions matter most for prenatal findings of Aprosencephaly, delivery planning, and discussing risks for future pregnancies. Interactions can look very different from person to person, so coordinated care and genetic counseling can help families understand what applies in their situation.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described newborns with severe brain and skull differences, often without knowing why these changes occurred. Midwives and physicians recorded rare cases where the front part of the brain and the structures that connect the two halves were missing or poorly formed. Families and communities once noticed patterns in which some pregnancies ended early, and some babies were born with profound differences in head shape and facial development, but the underlying cause remained unclear.
First described in the medical literature as a distinct pattern only in the 20th century, aprosencephaly was initially grouped with other conditions that affect early brain formation, such as anencephaly and holoprosencephaly. Early reports relied on what could be seen after birth or on autopsy, and the language was often imprecise because imaging did not yet exist. Over time, descriptions became more specific as doctors recognized that aprosencephaly involves a near-total absence of the forebrain and its related structures, setting it apart from other neural tube and midline brain conditions.
From early theories to modern research, the story of aprosencephaly reflects advances in prenatal and neonatal care. The introduction of ultrasound in the late 20th century allowed providers to detect major brain differences during pregnancy, sometimes in the first or second trimester. Later, fetal MRI added clearer pictures, helping teams distinguish aprosencephaly from similar conditions and guide counseling for families. These tools also made it possible to describe early symptoms of aprosencephaly seen on scans, like very small or absent forebrain tissue and changes in skull shape.
Advances in genetics have deepened understanding without changing the core clinical picture. Researchers discovered that some cases relate to changes in genes that steer very early brain development, while others may connect to disruptions during the first weeks after conception. Not every case has an identifiable genetic change, and many living with a family history never experience it again, which underscores the complexity of its causes.
In recent decades, awareness has grown that careful diagnosis matters for medical decisions, family planning, and support. Clearer definitions helped clinicians report cases consistently, compare findings across countries, and offer more accurate information about outcomes and recurrence risks. Despite evolving definitions, the central idea has stayed steady: aprosencephaly is a rare, severe disorder of early brain formation that begins in the earliest days of pregnancy.
Looking back helps explain why terminology sometimes varied in older records and why modern teams use multiple imaging studies and, when possible, genetic testing to confirm the diagnosis. Each stage in history has added to the picture we have today, bringing greater clarity, more compassionate counseling, and a shared language to discuss a difficult and rare condition.